These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 2334493
1. Reduction in ethanol preference following injection of centrally and peripherally acting antimuscarinic agents. Rezvani AH, Overstreet DH, Janowsky DS. Alcohol Alcohol; 1990; 25(1):3-7. PubMed ID: 2334493 [Abstract] [Full Text] [Related]
2. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression. Vargas HM, Ringdahl B. J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503 [Abstract] [Full Text] [Related]
3. Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. Rezvani AH, Overstreet DH, Janowsky DS. Alcohol Alcohol Suppl; 1991 Apr; 1():433-7. PubMed ID: 1845573 [Abstract] [Full Text] [Related]
4. Voluntary ethanol drinking during the first three postnatal weeks in lines of rats selectively bred for divergent ethanol preference. McKinzie DL, Cox R, Murphy JM, Li TK, Lumeng L, McBride WJ. Alcohol Clin Exp Res; 1999 Dec; 23(12):1892-7. PubMed ID: 10630607 [Abstract] [Full Text] [Related]
5. Comparison of in vitro actions with behavioral effects of antimuscarinic agents. Witkin JM, Gordon RK, Chiang PK. J Pharmacol Exp Ther; 1987 Sep; 242(3):796-803. PubMed ID: 3498817 [Abstract] [Full Text] [Related]
6. Ro 19-4603, a benzodiazepine receptor inverse agonist, attenuates voluntary ethanol consumption in rats selectively bred for high ethanol preference. Balakleevsky A, Colombo G, Fadda F, Gessa GL. Alcohol Alcohol; 1990 Sep; 25(5):449-52. PubMed ID: 1965120 [Abstract] [Full Text] [Related]
7. Atropine as an inhibitor of voluntary ethanol intake in male rats. Wahlström G, Nordberg A. Alcohol Alcohol; 1992 Jul; 27(4):381-91. PubMed ID: 1418113 [Abstract] [Full Text] [Related]
8. Responsivity and development of tolerance to the motor impairing effects of moderate doses of ethanol in alcohol-preferring (P) and -nonpreferring (NP) rat lines. Bell RL, Stewart RB, Woods JE, Lumeng L, Li TK, Murphy JM, McBride WJ. Alcohol Clin Exp Res; 2001 May; 25(5):644-50. PubMed ID: 11371712 [Abstract] [Full Text] [Related]
9. Prenatal alcohol exposure and offspring hyperactivity: effects of scopolamine and methylscopolamine. Bond NW. Neurobehav Toxicol Teratol; 1986 May; 8(3):287-92. PubMed ID: 3736758 [Abstract] [Full Text] [Related]
11. Comparison of alcohol-preferring and nonpreferring selectively bred rat lines. II. Operant self-administration in a continuous-access situation. Files FJ, Samson HH, Denning CE, Marvin S. Alcohol Clin Exp Res; 1998 Dec; 22(9):2147-58. PubMed ID: 9884163 [Abstract] [Full Text] [Related]
12. Animal model of ethanol abuse: rats selectively bred for high and low voluntary alcohol intake. Dyr W, Kostowski W. Acta Pol Pharm; 2000 Nov; 57 Suppl():90-2. PubMed ID: 11293278 [Abstract] [Full Text] [Related]
13. Comparison of the effects of scopolamine and methylscopolamine on the performance of a fixed-ratio discrimination in squirrel monkeys. Pakarinen ED, Moerschbaecher JM. Pharmacol Biochem Behav; 1993 Apr; 44(4):815-9. PubMed ID: 8469694 [Abstract] [Full Text] [Related]
14. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. Badia-Elder NE, Stewart RB, Powrozek TA, Murphy JM, Li TK. Alcohol Clin Exp Res; 2003 Jun; 27(6):894-9. PubMed ID: 12824809 [Abstract] [Full Text] [Related]